factor xiii deficiency in two spanish families with a novel variant in gene f13a1 detected by next-generation sequencing; symptoms and clinical management

Coagulation factor xiii (fxiii) has a major role in coagulation stabilizing the haemostatic clot. fxiii deficiency is associated with an increased risk of bleeding. severe phenotypes lead to spontaneous, traumatic and surgical bleeding. umbilical cord bleeding is especially common, and intracranial bleeding occur in up to one third of patients without prophylaxis. in this work, we used ngs for screening all the coding and intronic boundary regions of f13a1 and f13b genes in two families affected by severe fxiii deficiency. outcome confirmation analysis and variant studies in related patients was done by sanger sequencing. two variants were found: c.34a > g (p.arg12gly; nm_00129.3) and c.514c > t (p.arg172ter; nm_00129.3), both located in the f13a1 gene. the variant p.arg172ter is already described in literature and was found in homozygosis in one family and in compound heterozygosis in the other family. the variant p.arg12gly variant has not been described previously. this variant is located in the activation peptide of the fxiii a-subunit which is highly conserved among fxiii homologs. given the high risk of dangerous bleeding and early manifestation in severe fxiii-deficient patients, a prompt genetic confirmation is imperative. in this sense, ngs technology allows a rapid and simultaneous analysis of all regions of all the genes involved in the pathology.